Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic
Related posts
-
Arlington Heights mayor: Bears stadium not done deal
Arlington Heights Mayor Jim Tinaglia expressed caution about the Bears’ announced shift in stadium development focus... -
Yes, again: Long Grove’s covered bridge hit by box truck
Long Grove’s historic covered bridge was hit by a truck Monday, adding yet another to the... -
What’s the dog got? It’s baby animal season — how to protect critters and stay sane
A look inside DuPage Wildlife Conservation Center as they care for injured animals, plus tips on...